BMY
Bristol-Myers Squibb Co
Price:  
48.52 
USD
Volume:  
14,725,647.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy DCF Valuation - Growth Exit 5Y

-371.5%
Upside

What is the DCF valuation of Bmy??

The Discounted Cash Flow (DCF) valuation of Bristol-Myers Squibb Co (BMY) is (131.72) USD. With the latest stock price at 48.52 USD, the upside of Bristol-Myers Squibb Co based on DCF is -371.5%.

Is Bmy a buy or a sell?

Based on the latest price of 48.52 USD and our DCF valuation, Bristol-Myers Squibb Co (BMY) is a sell. selling Bmy stocks now will result in a potential gain of 371.5%.

Note: valuation result may not be accurate due to the low predictability of business.

Range Selected
WACC / Discount Rate 5.1% - 6.7% 5.9%
Long-term Growth Rate 3.0% - 4.9% 3.9%
Fair Price (878.72) - (81.52) (131.72)
Upside -1911.0% - -268.0% -371.5%
48.52 USD
Stock Price
(131.72) USD
Fair Price